title: [Clinical observation of compound xiatianwu tablets in treatment of 120 cases with active rheumatoid arthritis].
abstract: OBJECTIVE
  To observe the clinical efficacy of Compound Xiatianwu tablets in the treatment of active rheumatoid arthritis.
  
  
  METHODS
  One hundred and eighty cases with active rheumatoid arthritis were randomly divided into the control group (60 cases) with leflunomide, sulfasalazine, and celecoxib; the treatment group (120 cases) given compound Xiatianwu tablets on the basis of the control group, 2 tablets each time, 3 times/day, with the course of treatment of 3 month. Patients of the two groups were observed for clinical symptoms, erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, and immunoglobulin changes before and after the treatment.
  
  
  RESULTS
  The treatment group showed an overall efficiency of 94. 2% , the Xiatianwu group showed an overall efficiency of 80. 0%, while the control group showed an overall efficiency of 81.7%. The difference among the three groups was statistically significant (P <0. 05 or P <0. 01) , indicating that the treatment group was superior to the Xiatianwu group, while the Xiatianwu group was superior to the control group.
  
  
  CONCLUSIONS
  Compound Xiatianwu tablets has remarkable effect in the treatment of active rheumatoid arthritis.
authors.affiliation: Henan Nanyang Zhang Zhongjing Hospital, Nanyang 473000, China. ysyinfo@126.com
authors.forename: Shou-Yuan
authors.initials: SY
authors.lastname: Yu
authors.forename: Zhao-An
authors.initials: ZA
authors.lastname: Yu
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002097:C-Reactive Protein / Q000378:metabolism; D004365:Drugs, Chinese Herbal / Q000494:pharmacology / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D013607:Tablets; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal; D007136:Immunoglobulins; D013607:Tablets; D002097:C-Reactive Protein